RE:$0.165 New Low"New lows all the time and Proph... has nothing better to do than tell us new fairy tales every day."
fossi promotes the fantasy of a quick tripling of revenue with PGX and then bashes CZO for finding the capital to get CZO there in a very difficult financing enviroment for microcap biotech. fossi's make believe world is no financing required for a rapid tripling of revenue. PGX revenue magically triples without capital. When Gilles announces a plan to get the capital without warrants and with other benefits fossi takes to the message board to damage CZO's chances of getting it. fossi wants to live in a perpetual fantasy world of rapidly rising revenue with no additional capital required.
Carolyn Egbert, Chair of Aeterna: “Ceapro has well-established and growing commercial operations, with potential value-creating pipeline opportunities in large and growing cosmetic and consumer health markets. We believe that the new company will have the capital resources to support this ongoing growth..."
With the details to be released on the merger around the end of the month and arguably the most important biotech executuve in Canada "thrilled" about the merger without hearing the details fossi bashes the company. What's fossi's stnding in the biotech industry the last 20 years? fossi is upset his fantasy of a rapid tripling of revenue without any additional capital isn't being realized.
“We are thrilled with this exciting transaction to merge with Aeterna and combine two complementary companies and teams, in support of our plan to drive significant growth,” said Ronnie Miller, Chairman of Ceapro. “After careful consideration, we believe this transaction is the best way forward for Ceapro and our valued shareholders.”